Does the Use of Dihydroartemisinin-Piperaquine in Treating Patients with Uncomplicated falciparum Malaria Reduce the Risk for Recurrent New falciparum Infection More Than Artemether-Lumefantrine?
Table 7
Findings on new falciparum infections detected by day 28.
This result shows 79% reduction in incidence of new falciparum infections in favour of DP treatment and the reduction is statistically significant. The lowest plausible reduction is 67.9% while the highest is 86.6% as defined by the 95% CI of the RR.
DP treatment was associated with a 66.7% reduction in risk for a patient to acquire new infections compared to AL. The reduction is not statistically significant.